Skip to main content
. Author manuscript; available in PMC: 2017 Nov 1.
Published in final edited form as: Cancer Immunol Res. 2016 Oct 13;4(11):927–935. doi: 10.1158/2326-6066.CIR-16-0112

Table 3.

let-7a and let-7b expression and T-cell densities in colorectal cancer tissue

let-7a expression Univariate OR (95% CI) Multivariate OR (95% CI) let-7b expression Univariate OR (95% CI) Multivariate OR (95% CI)
Model of CD3+ cell density as a binary outcome (n = 514)a
 Q1 1 (reference) 1 (reference) Q1 1 (reference) 1 (reference)
 Q2 0.61 (0.37–1.01) 0.62 (0.37–1.03) Q2 1.82 (1.11–2.98) 1.75 (1.06–2.88)
 Q3 0.81 (0.49–1.36) 0.82 (0.49–1.39) Q3 1.89 (1.15–3.09) 1.67 (1.01–2.78)
 Q4 0.41 (0.25–0.68) 0.40 (0.23–0.67) Q4 1.40 (0.85–2.32) 1.30 (0.78–2.18)
Ptrendb 0.004 0.003 Ptrendb 0.18 0.40
Model of CD8+ cell density as a binary outcome (n = 506)a
 Q1 1 (reference) 1 (reference) Q1 1 (reference) 1 (reference)
 Q2 1.08 (0.66–1.79) 1.05 (0.63–1.76) Q2 1.01 (0.61–1.66) 1.03 (0.61–1.72)
 Q3 0.81 (0.49–1.33) 0.77 (0.46–1.29) Q3 1.47 (0.90–2.41) 1.47 (0.88–2.47)
 Q4 0.55 (0.34–0.92) 0.54 (0.32–0.91) Q4 1.80 (1.09–2.99) 1.59 (0.94–2.69)
Ptrendb 0.010 0.008 Ptrendb 0.008 0.04
Model of CD45RO+ cell density as a binary outcome (n = 518)a
 Q1 1 (reference) 1 (reference) Q1 1 (reference) 1 (reference)
 Q2 0.50 (0.29–0.87) 0.50 (0.28–0.88) Q2 1.22 (0.71–2.11) 1.34 (0.76–2.36)
 Q3 0.60 (0.35–1.03) 0.52 (0.30–0.92) Q3 1.18 (0.68–2.04) 1.32 (0.75–2.31)
 Q4 0.33 (0.18–0.60) 0.31 (0.17–0.58) Q4 0.48 (0.25–0.92) 0.52 (0.27–1.00)
Ptrendb 0.001 0.0004 Ptrendb 0.05 0.09
Model of FOXP3+ cell density as a binary outcome (n = 491)a
 Q1 1 (reference) 1 (reference) Q1 1 (reference) 1 (reference)
 Q2 1.01 (0.61–1.68) 1.07 (0.64–1.81) Q2 1.12 (0.68–1.85) 1.09 (0.65–1.83)
 Q3 0.94 (0.57–1.57) 0.89 (0.53–1.51) Q3 1.26 (0.76–2.07) 1.17 (0.70–1.96)
 Q4 1.06 (0.64–1.76) 1.00 (0.60–1.68) Q4 0.76 (0.45–1.27) 0.77 (0.46–1.32)
Ptrendb 0.88 0.84 Ptrendb 0.40 0.43
a

The multivariate logistic regression model initially included age, sex, year of diagnosis, family history of colorectal cancer in parent or sibling, tumor location, microsatellite instability, CpG island methylator phenotype, KRAS, BRAF, and PIK3CA mutations, and LINE-1 methylation level. A backward stepwise elimination with a threshold of P < 0.05 was used to select variables in the final models.

b

Ptrend was calculated by the linear trend test across the ordinal categories (first to fourth quartile) of let-7a or let-7b expression as a continuous variable in the logistic regression model for the density of CD3+, CD8+, CD45RO+, or FOXP3+ cells as a binary outcome variable. We adjusted two-sided α level to 0.006 (= 0.05/8) by simple Bonferroni correction.

CI, confidence interval; Q1 to Q4, quartile 1 (lowest) to quartile 4 (highest).